Pontifax Venture Capital

Portfolio Co Investors 2026 for Pontifax Venture Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Pontifax Venture Capital accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $855M. The median disclosed raise is $124M, and the largest is Silverback Therapeutics at $210M, ahead of Step Pharma ($146M) and Adcytherix ($144M).

The names that recur most often on these co-invested cap tables are Pontifax Venture Capital (8 companies), Kurma Partners (4 companies), Bpifrance (3 companies), RA Capital Management (3 companies), OrbiMed Advisors (2 companies), V-Bio Ventures (2 companies). By latest disclosed round, the market skews Series A (3), Series C (2), Series B (2), Growth (1).

Best funded Pontifax Venture Capital companies

  1. Silverback Therapeutics — $210M (latest: Series C)
  2. Step Pharma — $146M (latest: Series C)
  3. Adcytherix — $144M (latest: Series A)
  4. Precirix — $124M (latest: Series B)
  5. Emergence Therapeutics — $94M (latest: Series A)
  6. Saniona — $65M (latest: Growth)
  7. FoRx Therapeutics — $61M (latest: Series A)
  8. Germitec SAS — $11M (latest: Series B)

Pontifax Venture Capital — related firms and companies (51)

Pontifax Venture Capital alternatives · All research reports